Two regimens of docetaxel for metastatic breast cancer

被引：0
|
作者：
Andrew D. Seidman
Larry Norton
机构：
来源：
Current Oncology Reports | 2005年 / 7卷 / 1期
关键词：
Paclitaxel; Docetaxel; Trastuzumab; Metastatic Breast Cancer; Febrile Neutropenia;
D O I：
10.1007/s11912-005-0016-y
中图分类号：
学科分类号：
摘要：
All cancer therapy seeks to balance maximum anticancer efficacy with minimal toxicity. This study suggests, but because of the small sample size does not prove, that weekly administration of docetaxel is better tolerated without loss of efficacy.
引用
收藏
页码：7 / 7
相关论文
共 50 条
  • [41] Gemcitabine and docetaxel in metastatic breast cancer - further experience.
    Laufman, LR
    Spiridonidis, CH
    Boury, P
    Parker, T
    Glaub, E
    Maggard, V
    Miller, S
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S206 - S206
  • [42] Gemcitabine and docetaxel in metastatic and neoadjuvant treatment of breast cancer - Introduction
    McVie, G
    SEMINARS IN ONCOLOGY, 2004, 31 (02) : 1 - 1
  • [43] Study of tesmilifene plus docetaxel in metastatic breast cancer launched
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (09): : 1110 - +
  • [44] PANVAC vaccine alone or with docetaxel for patients with metastatic breast cancer
    Mohebtash, M.
    Madan, R. A.
    Gulley, J. L.
    Jones, J.
    Pazdur, M.
    Rauckhorst, M.
    Schlom, J.
    Arlen, P. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer
    Arrondeau, Jennifer
    Cottu, P.
    ONCOLOGIE, 2012, 14 (05) : 351 - 352
  • [46] Capecitabine plus docetaxel combination chemotherapy for metastatic breast cancer
    Saeki T.
    Takashima S.
    Breast Cancer, 2004, 11 (2) : 116 - 120
  • [47] Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
    Baselga, Jose
    Cortes, Javier
    Kim, Sung-Bae
    Im, Seock-Ah
    Hegg, Roberto
    Im, Young-Hyuck
    Roman, Laslo
    Pedrini, Jose Luiz
    Pienkowski, Tadeusz
    Knott, Adam
    Clark, Emma
    Benyunes, Mark C.
    Ross, Graham
    Swain, Sandra M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02): : 109 - 119
  • [48] Docetaxel in combination with epirubicin in metastatic breast cancer: pharmacokinetic interactions
    Ceruti, M
    Tagini, V
    Recalenda, V
    Arpicco, S
    Cattel, L
    Airoldi, M
    Bumma, C
    FARMACO, 1999, 54 (11-12): : 733 - 739
  • [49] Feasibility of docetaxel (D)-containing regimens in the adjuvant treatment (AT) of breast cancer (BC)
    Di Leo, A
    Crown, J
    Nogaret, JM
    Duffy, K
    Bartholomeus, S
    Rowan, S
    Dolci, S
    O'Higgins, N
    Riva, A
    Piccart, MJ
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S36 - S36
  • [50] Docetaxel more effective than standard metastatic breast cancer treatments in two phase III trials
    不详
    FORMULARY, 1997, 32 (08) : 794 - 794
12345